By name: "KSB-D03-K0039" description: "Pharmacokinetic Modeling: AI-enhanced dose optimization and ADR risk minimization..." version: "1.0.0" domain: "D03" domain_name: "Important ADRs Recognition" type: "Knowledge" proficiency_level: "L1" bloom_level: "understand" triggers: - "explain pharmacokinetic modeling" - "what is pharmacokinetic modeling" - "explain pharmacokinetic modeling" epa_mapping: "EPA-01, EPA-02, EPA-05" cpa_mapping: "CPA-01, CPA-02" regulatory_refs: "ICH-E2A, EMA-GVP-014, EMA-GVP-015"
KSB-D03-K0039: Pharmacokinetic Modeling
Overview
Domain: D03 - Important ADRs Recognition Type: Knowledge Proficiency Level: L1 (Novice - Direct supervision required) Bloom Level: Understand
Description
AI-enhanced dose optimization and ADR risk minimization
Context
- Major Section: Organ System-Specific ADR Patterns
- Section: Real-Time Monitoring Systems
EPA Mapping
- EPA-01:3001-3003
- EPA-02:3004-3005
- EPA-05:3011-3012
CPA Pathway
- CPA-01, CPA-02
Regulatory References
- ICH-E2A
- EMA-GVP-014
- EMA-GVP-015
Instructions
When this skill is activated, Claude should:
- Demonstrate L1 proficiency in pharmacokinetic modeling
- Apply understand level cognitive skills to explain the topic
- Reference relevant regulatory guidance (ICH-E2A, EMA-GVP-014, EMA-GVP-015)
- Connect to related EPAs: EPA-01, EPA-02, EPA-05
Key Competencies
- AI-enhanced dose optimization and ADR risk minimization
Assessment Criteria
- Can explain core concepts independently
- Demonstrates understanding of regulatory context
- Applies knowledge appropriately to PV scenarios
Related Skills
- Other D03 skills in Real-Time Monitoring Systems
- Cross-domain integrations per DAG architecture
Generated from PV KSB Framework v1.0 | 2025-12-31